Actualyze AI
An enterprise gateway for AI-model access, request security, budgets and routing.
$7MSeed
Role not disclosedCP
Canaan Partners
Activity from announced rounds
Activity in this selectionOct 23, 2026 · AI · Jul 26, 2026
Canaan Partners is an investment firm whose company directory identifies Draig Therapeutics and Solstice Oncology.
Recorded funding activity
Draig develops neuropsychiatric medicines, while Solstice advances an engineered CTLA-4 antibody for cancer treatment. The recorded history also includes Actualyze AI’s enterprise gateway for model access, request security, budgets and routing. Named regional funds retain separate identities.
Sources
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $7M 1 disclosed · full round size, not this investor’s share